Hepenofovir fumarate
富马酸海普诺福韦
Report date: 2026/04/20 20:01:59
NME
Base Information
Drug NameHepenofovir fumarate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesGuangdong Qifang Medicine Co LtdXi'an Xintong Pharmaceutical Research Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A